M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis.

PLoS One · 2011 · PMC3116871 · PMID 21698156

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significancep = 0.10so close (0.05 < p ≤ 0.1)

showed a trendno p-value reported

M402 monotherapy showed a trend towards improved survival, but did not reach statistical significance in this study (p = 0.10 by Log-Rank test).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.